Drug Shortage Report for SUBLOCADE

Last updated on 2020-09-21 History
Report ID 123461
Drug Identification Number 02483084
Brand name SUBLOCADE
Common or Proper name Buprenorphine extended release injection
Company Name INDIVIOR UK LIMITED
Market Status MARKETED
Active Ingredient(s) BUPRENORPHINE
Strength(s) 100MG
Dosage form(s) SOLUTION (EXTENDED RELEASE)
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 syringe/pouch
ATC code N07BC
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-09-01
Actual start date 2020-09-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-09-21
Company comments https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods/information-provisions-related-drugs-biocides/tier-3-shortages.html
Health Canada comments
Contact Address THE CHAPLEO BUILDING, HENRY BOOT WAY
HULL, --
UNITED KINGDOM HU4 7DY
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-09-21 French Compare
v6 2020-09-21 English Compare
v5 2020-09-02 English Compare
v4 2020-09-01 French Compare
v3 2020-09-01 English Compare
v2 2020-09-01 English Compare
v1 2020-09-01 English Compare